Abstract:Metabolism and detection of methandienone in urine are well established in horses, but there is limited knowledge about its metabolites in plasma and no information about its detection in hair. Following an oral administration, nine Phase I metabolites were observed in plasma, and the longest detection time was achieved by targeting the parent compound and the mono‐hydroxylated metabolite. In hair, the parent compound and hydroxylated metabolites were detected and the mono‐hydroxylated offered the longest detection time. Methandienone is an anabolic‐androgenic steroid that is prohibited in equine sports due to its potential performance enhancing properties. Metabolism and detection of methandienone in equine urine have been investigated comprehensively in literature; however, there is a limited knowledge about its metabolites in equine plasma and no information about its detection in equine hair. Following a multi‐dose oral administration of methandienone to two Thoroughbred horses, 17‐epimethandienone, methyltestosterone, two mono‐hydroxylated, two di‐hydroxylated and three 17α‐methylandrostanetriol metabolites were detected in plasma. The majority of these were present as free analytes, whilst the mono‐hydroxylated metabolites and one isomer of 17α‐methylandrostanetriol were partially conjugated. Estimated peak concentrations of methandienone were 6,000 and 11,100 pg/ml; meanwhile, they were 25.4 and 40.5 pg/ml for methyltestosterone. The most abundant analyte in the post‐administration plasma samples of both horses was the mono‐hydroxylated metabolite; however, the parent compound provided the longest detection (up to 96 h). Screening analysis of hair enabled the detection of methandienone in mane hair samples only, for up to 3 months. Its mono‐ and di‐hydroxylated metabolites were detected with greater peak responses for up to 6 months post‐administration in both mane and tail samples, showing that these metabolites could be better analytical targets for hair analysis when administered orally. A follow‐up methodology with an extensive wash procedure confirmed the presence of methandienone and its metabolites in a number of post‐administration hair samples. Final wash samples were also analysed to assess the degree of internal incorporation (via bloodstream) against possible external deposition (via sweat/sebum).

Quantification of osilodrostat in horse urine using LC/ESI-HRMS to establish an elimination profile for doping control

Metabolic Pathway of Osilodrostat in Equine Urine Established through High-resolution Mass Spectrometric Characterization for Doping Control

Pharmacokinetic study of osilodrostat and identification of mono‐hydroxylated metabolite in equine plasma for the purpose of doping control

Broad‐spectrum and sensitive screening of more than 1000 compounds in equine urine using liquid chromatography/high‐resolution mass spectrometry

Direct injection horse urine analysis for the quantification and identification of threshold substances for doping control. III. Determination of salicylic acid by liquid chromatography/quadrupole time-of-flight mass spectrometry

A Broad-Spectrum Peptide Screening Method Using an Optimized Solid-Phase Extraction and Liquid Chromatography–High-Field Asymmetric Ion Mobility Spectrometry–Mass Spectrometry for Doping Control in Equine Urine

Detection of FG‐4592 and metabolites in equine plasma, urine and hair following oral administration

A steroidomic approach for biomarkers discovery in doping control

A rapid and sensitive method for the quantitative analysis of ibuprofen and its metabolites in equine urine samples by gas chromatography with tandem mass spectrometry.

Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control

New drostanolone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control

Detection of the selective androgen receptor modulator S-23 and its metabolites in equine urine and plasma following oral administration

Detection of methandienone and its metabolites in equine urine, plasma and hair following a multidose oral administration

Detection of Over 110 Anabolic–Androgenic Steroids, Corticosteroids and/or Their Esters in Horse Hair Using Ultra‐High‐Performance Liquid Chromatography–High‐Resolution Mass Spectrometry and Gas Chromatography–Tandem Mass Spectrometry After Solid‐Supported Liquid Extraction

Doping control analysis of myo‐inositol trispyrophosphate and 10 bisphosphonates in equine plasma by ion chromatography–mass spectrometry and its application to clodronic acid horse administration

Identification and differentiation of somapacitan, a long-acting growth hormone derivative, and recombinant human growth hormone in equine plasma by LC-HRMS for doping control purpose

Analysis of loxoprofen in tablets, patches, and equine urine as tert-butyldimethylsilyl derivative by gas chromatography-mass spectrometry

Simultaneous and Rapid Screening of 39 Prohibited Drugs in Horse Feed Using Liquid Chromatography-Tandem Mass Spectrometry

Development and validation of general plasma screening method for performance enhancing drugs in racehorses utilizing liquid chromatography-high-resolution mass spectrometry (LC-HRMS)

3-Methoxytyrosine as an indicator of dopaminergic manipulation in equine plasma